Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · BILL · 117th Congress · S. 4348 (Reported in Senate) — To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs,... · Sec. 828

Sec. 828. Combination products

342 words·~2 min read·/bill/117/s/4348/rs/section-828

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 503(g) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353(g) ) is amended— in paragraph (1)— in subparagraph (A), by striking or biological product and inserting in vitro clinical test, or biological product (except for a product constituted of a device and an in vitro clinical test) ; in subparagraph (B), by adding at the end the following: For purposes of this Act, a product that constitutes a combination of a drug and an in vitro clinical test is not a combination product within the meaning of this subsection. ; and in subparagraph (D)(ii)— by inserting or in vitro clinical test after device ; and by inserting and in vitro clinical tests before shall ; in paragraph (3), by striking safety and effectiveness or substantial equivalence and inserting safety and effectiveness, substantial equivalence, or analytical validity and clinical validity before for the approved constituent part ; in paragraph (4)— in subparagraph (A), by striking or 513(f)(2) (submitted in accordance with paragraph (5)) and inserting 513(f)(2) (submitted in accordance with paragraph (5)), 587B, or 587D, or an exempt test under section 587C, as applicable ; and in subparagraph (B), by inserting , 587B, or 587D after section 515 ; in paragraph (5)(A), by striking or 510(k) and inserting , 510(k), 587B, or 587D ; in paragraph (7), by striking or substantial equivalence and inserting , substantial equivalence, or analytical validity and clinical validity ; in paragraph (8), by adding at the end the following:
This paragraph shall not apply to a product constituted of a device and an in vitro clinical test. ; and in paragraph (9)— in subparagraph (C)(i), by striking or 520(g) and inserting 520(g), 587B, or 587D ; and in subparagraph (D), by striking or 520 and inserting 520, 587B, or 587D . Section 563 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–2 ) is amended by adding at the end the following: This section shall not apply to a product constituted of a device and an in vitro clinical test. .
Connectionstraces to 1
1 reference not yet in our index
  • 21 USC 360bbb–2
Citation graph
cites case law
Sec. 828
Combination products
Cite21 USC 360bbb–2
Cites 2Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.